Hengyang Key Laboratory of Hemorrhagic Cerebrovascular Disease, Department of Neurosurgery, The Second Affiliated Hospital, Hengyang Medical School University of South China, Hengyang, Hunan, China.
Beijing Neurosurgical Institute, Capital Medical University, Beijing, China; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Beijing, China.
World Neurosurg. 2022 Oct;166:e245-e252. doi: 10.1016/j.wneu.2022.06.147. Epub 2022 Jul 6.
The Subarachnoid Hemorrhage Early Brain Edema Score (SEBES) is a radiographic marker for early brain injury after aneurysmal subarachnoid hemorrhage (aSAH). We evaluated the role of the SEBES in performing decompressive craniectomy (DC) for poor-grade aSAH.
We retrospectively analyzed all cases of poor-grade (World Federation of Neurosurgical Societies [WFNS] grade IV and V) aSAH in adults who underwent microsurgery at our center between April 2017 and March 2021. Patient demographics, clinical presentation, imaging findings, and surgical data were obtained. The study endpoints of DC rate, complications, and functional outcomes (modified Rankin Scale score >3) were compared between the traditional surgery and SEBES-informed groups. A survival analysis was performed to estimate 180-day survival and hazard ratios for death.
The study included 116 patients (mean age, 60.8 ± 9.5 years, DCs [n = 63, 54.3%]). In the univariate analysis, age, intracranial pressure, midline shift, pupil changes, SEBES grade III-IV, traditional group, and WFNS grade Ⅴ were associated with DC. DC (46.4% vs. 67.4%) and in-hospital mortality rates (9.6% vs. 25.6%) were significantly lower in the SEBES-informed group. At day 180 after admission, modified Rankin Scale scores did not significantly differ between the 2 groups, but 180-day survival was significantly higher in the SEBES-informed group (78.1% vs. 53.5%). In the multivariable analysis, age, pupil changes, being in the traditional group, and delayed cerebral ischemia were independently associated with 180-day postadmission mortality.
The SEBES provides good imaging support for preoperative and intraoperative intracranial pressure management in poor-grade aSAH, allowing for improved DC-related decision-making and better 180-day survival.
蛛网膜下腔出血早期脑水肿评分(SEBES)是蛛网膜下腔出血(aSAH)后早期脑损伤的影像学标志物。我们评估了 SEBES 在为低分级 aSAH 行去骨瓣减压术(DC)中的作用。
我们回顾性分析了 2017 年 4 月至 2021 年 3 月在我中心接受显微手术治疗的低分级(世界神经外科学会联合会[WFNS]分级 IV 和 V)成人 aSAH 所有病例。获取患者人口统计学、临床表现、影像学发现和手术数据。比较传统手术组和 SEBES 指导组的 DC 率、并发症和功能结局(改良 Rankin 量表评分>3)。进行生存分析以估计 180 天生存率和死亡的危险比。
本研究共纳入 116 例患者(平均年龄 60.8±9.5 岁,行 DC[63 例,54.3%])。单因素分析中,年龄、颅内压、中线移位、瞳孔变化、SEBES 分级 III-IV、传统组和 WFNS 分级 V 与 DC 相关。SEBES 指导组的 DC(46.4% vs. 67.4%)和住院死亡率(9.6% vs. 25.6%)显著降低。入院后 180 天,两组改良 Rankin 量表评分无显著差异,但 SEBES 指导组 180 天生存率显著较高(78.1% vs. 53.5%)。多变量分析中,年龄、瞳孔变化、传统组和迟发性脑缺血与 180 天后的入院死亡率独立相关。
SEBES 为低分级 aSAH 术前和术中颅内压管理提供了良好的影像学支持,有助于更好地做出与 DC 相关的决策,并提高 180 天生存率。